Skip to main content
Erschienen in: Journal of Neurology 2/2016

01.02.2016 | Original Communication

Defining the phenotype of restless legs syndrome/Willis–Ekbom disease (RLS/WED): a clinical and polysomnographic study

verfasst von: Fabrizio Rinaldi, Andrea Galbiati, Sara Marelli, Maria Cusmai, Alessandro Gasperi, Alessandro Oldani, Marco Zucconi, Alessandro Padovani, Luigi Ferini Strambi

Erschienen in: Journal of Neurology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Clinical features variability between familial and sporadic restless legs syndrome/Willis–Ekbom disease (RLS/WED) has been previously reported. With this retrospective cohort study, we aimed to determine the clinical and polysomnographic characteristics of 400 RLS/WED patients. Patients with familial RLS/WED were significantly younger than sporadic RLS/WED, while clinical and polysomnographic characteristics were similar in both groups. No difference was found for the age-at-onset between idiopathic and secondary RLS/WED. Periodic limb movements (PLM) index and REM sleep time were higher in idiopathic RLS/WED. Time of onset of symptoms was in the evening or at bedtime in 28.04 and 37.80 % of patients, respectively, while in 21.34 % of patients onset was more than 1 h after sleep onset. Impulse control and compulsive behaviours (ICBs) were found in 13.29 % patients on dopamine agonist therapy. Our analyses support the hypothesis that patients with a familial history of RLS/WED may have a genetic component. Nevertheless, the dichotomy between early and late onset disease seems to be less sharp than previously reported. A large proportion of RLS/WED patients can have atypical features, therefore making the diagnosis challenging. Some cases can be missed even when the patient refers to a sleep specialist, as revealed by the partial absence of daytime symptoms, the high comorbidity with insomnia and other sleep complaints and the high percentage of symptoms beginning after sleep onset. This draws attention on the importance of a careful evaluation of the patient, to recognize potentially treatable secondary forms of RLS/WED.
Literatur
1.
Zurück zum Zitat Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB, International Restless Legs Syndrome Study Group (2014) Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria—history, rationale, description, and significance. Sleep Med 15(8):860–873CrossRefPubMed Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB, International Restless Legs Syndrome Study Group (2014) Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria—history, rationale, description, and significance. Sleep Med 15(8):860–873CrossRefPubMed
2.
Zurück zum Zitat Chabli A, Michaud M, Montplaisir J (2000) Periodic arm movements in patients with the restless legs syndrome. Eur Neurol 44(3):133–138CrossRefPubMed Chabli A, Michaud M, Montplaisir J (2000) Periodic arm movements in patients with the restless legs syndrome. Eur Neurol 44(3):133–138CrossRefPubMed
3.
Zurück zum Zitat Garcia-Borreguero D, Egatz R, Winkelmann J, Berger K (2006) Epidemiology of restless legs syndrome: the current status. Sleep Med Rev 10(3):153–167CrossRefPubMed Garcia-Borreguero D, Egatz R, Winkelmann J, Berger K (2006) Epidemiology of restless legs syndrome: the current status. Sleep Med Rev 10(3):153–167CrossRefPubMed
4.
5.
Zurück zum Zitat Winkelmann J, Muller-Myhsok B, Wittchen HU, Hock B, Prager M, Pfister H, Strohle A, Eisensehr I, Dichgans M, Gasser T, Trenkwalder C (2002) Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Ann Neurol 52(3):297–302CrossRefPubMed Winkelmann J, Muller-Myhsok B, Wittchen HU, Hock B, Prager M, Pfister H, Strohle A, Eisensehr I, Dichgans M, Gasser T, Trenkwalder C (2002) Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Ann Neurol 52(3):297–302CrossRefPubMed
6.
Zurück zum Zitat Allen RP, La Buda MC, Becker P, Earley CJ (2002) Family history study of the restless legs syndrome. Sleep Med 3(Suppl):S3–S7CrossRefPubMed Allen RP, La Buda MC, Becker P, Earley CJ (2002) Family history study of the restless legs syndrome. Sleep Med 3(Suppl):S3–S7CrossRefPubMed
7.
Zurück zum Zitat Aul EA, Davis BD, Rodnitzky RL (1998) The importance of formal serum iron studies in the assessment of restless legs syndrome. Neurology 51(3):912CrossRefPubMed Aul EA, Davis BD, Rodnitzky RL (1998) The importance of formal serum iron studies in the assessment of restless legs syndrome. Neurology 51(3):912CrossRefPubMed
8.
Zurück zum Zitat Winkelman JW, Chertow GM, Lazarus JM (1996) Restless legs syndrome in end-stage renal disease. Am J Kidney Dis 28(3):372–378CrossRefPubMed Winkelman JW, Chertow GM, Lazarus JM (1996) Restless legs syndrome in end-stage renal disease. Am J Kidney Dis 28(3):372–378CrossRefPubMed
9.
Zurück zum Zitat Ondo W, Jankovic J (1996) Restless legs syndrome: clinicoetiologic correlates. Neurology 47:1435–1441CrossRefPubMed Ondo W, Jankovic J (1996) Restless legs syndrome: clinicoetiologic correlates. Neurology 47:1435–1441CrossRefPubMed
11.
Zurück zum Zitat O’Keeffe ST, Gavin K, Lavan JN (1994) Iron status and restless legs syndrome in the elderly. Age Ageing 23(3):200–203CrossRefPubMed O’Keeffe ST, Gavin K, Lavan JN (1994) Iron status and restless legs syndrome in the elderly. Age Ageing 23(3):200–203CrossRefPubMed
12.
Zurück zum Zitat Sun ER, Chen CA, Ho G, Earley CJ, Allen RP (1998) Iron and the restless legs syndrome. Sleep 21(4):371–377CrossRefPubMed Sun ER, Chen CA, Ho G, Earley CJ, Allen RP (1998) Iron and the restless legs syndrome. Sleep 21(4):371–377CrossRefPubMed
13.
Zurück zum Zitat Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J, Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health, International Restless Legs Syndrome Study Group (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4(2):101–119CrossRefPubMed Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J, Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health, International Restless Legs Syndrome Study Group (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4(2):101–119CrossRefPubMed
14.
Zurück zum Zitat Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C, International Restless Legs Syndrome Study Group (2003) Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 4(2):121–132CrossRefPubMed Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C, International Restless Legs Syndrome Study Group (2003) Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 4(2):121–132CrossRefPubMed
15.
Zurück zum Zitat Iber C, Ancoli-Israel S, Chesson AL, Quan SF, For the American Academy of Sleep Medicine (2007) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, 1st edn. American Academy of Sleep Medicine, Westchester Iber C, Ancoli-Israel S, Chesson AL, Quan SF, For the American Academy of Sleep Medicine (2007) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, 1st edn. American Academy of Sleep Medicine, Westchester
16.
Zurück zum Zitat Zucconi M, Ferri R, Allen R, Baier PC, Bruni O, Chokroverty S, Ferini-Strambi L, Fulda S, Garcia-Borreguero D, Hening WA, Hirshkowitz M, Högl B, Hornyak M, King M, Montagna P, Parrino L, Plazzi G, Terzano MG, International Restless Legs Syndrome Study Group (IRLSSG) (2006) The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG). Sleep Med 7(2):175–183CrossRefPubMed Zucconi M, Ferri R, Allen R, Baier PC, Bruni O, Chokroverty S, Ferini-Strambi L, Fulda S, Garcia-Borreguero D, Hening WA, Hirshkowitz M, Högl B, Hornyak M, King M, Montagna P, Parrino L, Plazzi G, Terzano MG, International Restless Legs Syndrome Study Group (IRLSSG) (2006) The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG). Sleep Med 7(2):175–183CrossRefPubMed
17.
Zurück zum Zitat Benediktsdottir B, Janson C, Lindberg E, Arnardóttir ES, Olafsson I, Cook E, Thorarinsdottir EH, Gislason T (2010) Prevalence of restless legs syndrome among adults in Iceland and Sweden: Lung function, comorbidity, ferritin, biomarkers and quality of life. Sleep Med 11(10):1043–1048CrossRefPubMed Benediktsdottir B, Janson C, Lindberg E, Arnardóttir ES, Olafsson I, Cook E, Thorarinsdottir EH, Gislason T (2010) Prevalence of restless legs syndrome among adults in Iceland and Sweden: Lung function, comorbidity, ferritin, biomarkers and quality of life. Sleep Med 11(10):1043–1048CrossRefPubMed
18.
Zurück zum Zitat Szentkirályi A, Völzke H, Hoffmann W, Trenkwalder C, Berger K (2014) Multimorbidity and the risk of restless legs syndrome in 2 prospective cohort studies. Neurology 82(22):2026–2033CrossRefPubMed Szentkirályi A, Völzke H, Hoffmann W, Trenkwalder C, Berger K (2014) Multimorbidity and the risk of restless legs syndrome in 2 prospective cohort studies. Neurology 82(22):2026–2033CrossRefPubMed
19.
Zurück zum Zitat Ulfberg J, Bjorvatn B, Leissner L, Gyring J, Karlsborg M, Regeur L, Skeidsvoll H, Polo O, Partinen M, Nordic RLS Study Group (2007) Comorbidity in restless legs syndrome among a sample of Swedish adults. Sleep Med 8(7–8):768–772CrossRefPubMed Ulfberg J, Bjorvatn B, Leissner L, Gyring J, Karlsborg M, Regeur L, Skeidsvoll H, Polo O, Partinen M, Nordic RLS Study Group (2007) Comorbidity in restless legs syndrome among a sample of Swedish adults. Sleep Med 8(7–8):768–772CrossRefPubMed
20.
Zurück zum Zitat Allen RP, Earley CJ (2000) Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset. Sleep Med 1(1):11–19CrossRefPubMed Allen RP, Earley CJ (2000) Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset. Sleep Med 1(1):11–19CrossRefPubMed
21.
Zurück zum Zitat Riemann D, Spiegelhalder K, Feige B, Voderholzer U, Berger M, Perlis M, Nissen C (2010) The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev 14(1):19–31CrossRefPubMed Riemann D, Spiegelhalder K, Feige B, Voderholzer U, Berger M, Perlis M, Nissen C (2010) The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev 14(1):19–31CrossRefPubMed
22.
Zurück zum Zitat Ferri R, Cosentino FI, Manconi M, Rundo F, Bruni O, Zucconi M (2014) Increased electroencephalographic high frequencies during the sleep onset period in patients with restless legs syndrome. Sleep 37(8):1375–1381CrossRefPubMedPubMedCentral Ferri R, Cosentino FI, Manconi M, Rundo F, Bruni O, Zucconi M (2014) Increased electroencephalographic high frequencies during the sleep onset period in patients with restless legs syndrome. Sleep 37(8):1375–1381CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Phillips B, Hening W, Britz P, Mannino D (2006) Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. Chest 129(1):76–80CrossRefPubMed Phillips B, Hening W, Britz P, Mannino D (2006) Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. Chest 129(1):76–80CrossRefPubMed
24.
Zurück zum Zitat Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K (2000) Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and morbidity in Augsburg elderly. Neurology 54(5):1064–1068CrossRefPubMed Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K (2000) Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and morbidity in Augsburg elderly. Neurology 54(5):1064–1068CrossRefPubMed
25.
Zurück zum Zitat Lavigne GJ, Montplaisir JY (1994) Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 17(8):739–743PubMed Lavigne GJ, Montplaisir JY (1994) Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 17(8):739–743PubMed
26.
Zurück zum Zitat Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C (2000) Epidemiology of restless legs symptoms in adults. Arch Internal Med 160(14):2137–2141CrossRef Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C (2000) Epidemiology of restless legs symptoms in adults. Arch Internal Med 160(14):2137–2141CrossRef
27.
Zurück zum Zitat Bonati M, Ferini-Strambi L, Aridon P, Oldani A, Zucconi M, Casari G (2003) Autosomal dominant restless legs syndrome maps an chromosome 14q. Brain 126(Pt 6):1485–1492CrossRefPubMed Bonati M, Ferini-Strambi L, Aridon P, Oldani A, Zucconi M, Casari G (2003) Autosomal dominant restless legs syndrome maps an chromosome 14q. Brain 126(Pt 6):1485–1492CrossRefPubMed
28.
Zurück zum Zitat Schormair B, Winkelmann J (2011) Genetics of restless legs syndrome: Mendelian, complex, and everything in between. Sleep Med Clin 6(2):203–215CrossRef Schormair B, Winkelmann J (2011) Genetics of restless legs syndrome: Mendelian, complex, and everything in between. Sleep Med Clin 6(2):203–215CrossRef
29.
Zurück zum Zitat Whittom S, Dauvilliers Y, Pennestri MH, Vercauteren F, Molinari N, Petit D, Montplaisir J (2007) Age-at-onset in restless legs syndrome: a clinical and polysomnographic study. Sleep Med 9(1):54–59CrossRefPubMed Whittom S, Dauvilliers Y, Pennestri MH, Vercauteren F, Molinari N, Petit D, Montplaisir J (2007) Age-at-onset in restless legs syndrome: a clinical and polysomnographic study. Sleep Med 9(1):54–59CrossRefPubMed
30.
Zurück zum Zitat Hanson M, Honour M, Singleton A, Crawley A, Singleton A, Hardy J, Gwinn-Hardy K (2004) Analysis of familial and sporadic restless legs syndrome in age of onset, gender, and severity features. J Neurol 251(11):1398–1401CrossRefPubMed Hanson M, Honour M, Singleton A, Crawley A, Singleton A, Hardy J, Gwinn-Hardy K (2004) Analysis of familial and sporadic restless legs syndrome in age of onset, gender, and severity features. J Neurol 251(11):1398–1401CrossRefPubMed
31.
Zurück zum Zitat Collado-Seidel V, Kohnen R, Samtleben W, Hillebrand GF, Oertel WH, Trenkwalder C (1998) Clinical and biochemical findings in uremic patients with and without restless legs syndrome. Am J Kidney Dis 31(2):324–328CrossRefPubMed Collado-Seidel V, Kohnen R, Samtleben W, Hillebrand GF, Oertel WH, Trenkwalder C (1998) Clinical and biochemical findings in uremic patients with and without restless legs syndrome. Am J Kidney Dis 31(2):324–328CrossRefPubMed
32.
Zurück zum Zitat Reynolds G, Blake DR, Pall HS, Williams A (1986) Restless leg syndrome and rheumatoid arthritis. Br Med J (Clin Res Ed) 292(6521):659–660CrossRef Reynolds G, Blake DR, Pall HS, Williams A (1986) Restless leg syndrome and rheumatoid arthritis. Br Med J (Clin Res Ed) 292(6521):659–660CrossRef
33.
Zurück zum Zitat Heinze EG, Frame B, Fine G (1967) Restless legs and orthostatic hypotension in primary amyloidosis. Arch Neurol 16(5):497–500CrossRefPubMed Heinze EG, Frame B, Fine G (1967) Restless legs and orthostatic hypotension in primary amyloidosis. Arch Neurol 16(5):497–500CrossRefPubMed
34.
Zurück zum Zitat Botez MI, Lambert B (1977) Folate-deficiency and restless-legs-syndrome in pregnancy. N Engl J Med 297(12):670PubMed Botez MI, Lambert B (1977) Folate-deficiency and restless-legs-syndrome in pregnancy. N Engl J Med 297(12):670PubMed
35.
Zurück zum Zitat Lipford MC, Silber MH (2012) Long-term use of pramipexole in the management of restless legs syndrome. Sleep Med 13(10):1280–1285CrossRefPubMed Lipford MC, Silber MH (2012) Long-term use of pramipexole in the management of restless legs syndrome. Sleep Med 13(10):1280–1285CrossRefPubMed
36.
Zurück zum Zitat Ondo WG, Lai D (2008) Predictors of impulsivity and reward seeking behavior with dopamine agonists. Parkinsonism Relat Disord 14(1):28–32CrossRefPubMed Ondo WG, Lai D (2008) Predictors of impulsivity and reward seeking behavior with dopamine agonists. Parkinsonism Relat Disord 14(1):28–32CrossRefPubMed
37.
Zurück zum Zitat Pourcher E, Rémillard S, Cohen H (2010) Compulsive habits in restless legs syndrome patients under dopaminergic treatment. J Neurol Sci 290(1–2):52–56CrossRefPubMed Pourcher E, Rémillard S, Cohen H (2010) Compulsive habits in restless legs syndrome patients under dopaminergic treatment. J Neurol Sci 290(1–2):52–56CrossRefPubMed
38.
Zurück zum Zitat Cornelius JR, Tippmann-Peikert M, Slocumb NL, Frerichs CF, Silber MH (2010) Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep 33(1):81–87PubMedPubMedCentral Cornelius JR, Tippmann-Peikert M, Slocumb NL, Frerichs CF, Silber MH (2010) Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep 33(1):81–87PubMedPubMedCentral
39.
Zurück zum Zitat Schreglmann SR, Gantenbein AR, Eisele G, Baumann CR (2012) Transdermal rotigotine causes impulse control disorders in patients with restless legs syndrome. Parkinsonism Relat Disord 18(2):207–209CrossRefPubMed Schreglmann SR, Gantenbein AR, Eisele G, Baumann CR (2012) Transdermal rotigotine causes impulse control disorders in patients with restless legs syndrome. Parkinsonism Relat Disord 18(2):207–209CrossRefPubMed
40.
Zurück zum Zitat Voon V, Schoerling A, Wenzel S, Ekanayake V, Reiff J, Trenkwalder C, Sixel-Döring F (2011) Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome. BMC Neurol 11:117CrossRefPubMedPubMedCentral Voon V, Schoerling A, Wenzel S, Ekanayake V, Reiff J, Trenkwalder C, Sixel-Döring F (2011) Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome. BMC Neurol 11:117CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Garcia-Borreguero D, Kohnen R, Silber MH, Winkelman JW, Earley CJ, Högl B, Manconi M, Montplaisir J, Inoue Y, Allen RP (2013) The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group. Sleep Med 14(7):675–684CrossRefPubMed Garcia-Borreguero D, Kohnen R, Silber MH, Winkelman JW, Earley CJ, Högl B, Manconi M, Montplaisir J, Inoue Y, Allen RP (2013) The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group. Sleep Med 14(7):675–684CrossRefPubMed
42.
Zurück zum Zitat Montplaisir J, Nicolas A, Denesle R et al (1999) Restless legs syndrome improved by pramipexole. A double-blind randomized trial. Neurology 52:938–943CrossRefPubMed Montplaisir J, Nicolas A, Denesle R et al (1999) Restless legs syndrome improved by pramipexole. A double-blind randomized trial. Neurology 52:938–943CrossRefPubMed
43.
Zurück zum Zitat Saletu M, Anderer P, Saletu-Zyhlarz G et al (2002) Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome. Eur Arch Psychiatry Clin Neurosci 252:185–194CrossRefPubMed Saletu M, Anderer P, Saletu-Zyhlarz G et al (2002) Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome. Eur Arch Psychiatry Clin Neurosci 252:185–194CrossRefPubMed
Metadaten
Titel
Defining the phenotype of restless legs syndrome/Willis–Ekbom disease (RLS/WED): a clinical and polysomnographic study
verfasst von
Fabrizio Rinaldi
Andrea Galbiati
Sara Marelli
Maria Cusmai
Alessandro Gasperi
Alessandro Oldani
Marco Zucconi
Alessandro Padovani
Luigi Ferini Strambi
Publikationsdatum
01.02.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 2/2016
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-7994-y

Weitere Artikel der Ausgabe 2/2016

Journal of Neurology 2/2016 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.